Accessibility Menu
Arcadia Biosciences logo

Arcadia Biosciences

(NASDAQ) RKDA

Current Price$1.05
Market Cap$1.86M
Since IPO (2015)-100%
5 Year-99%
1 Year-82%
1 Month-15%

Arcadia Biosciences Financials at a Glance

Market Cap

$1.86M

Revenue (TTM)

$4.76M

Net Income (TTM)

-$9.32M

EPS (TTM)

-$5.72

P/E Ratio

-0.16

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$1.05

Volume

630,844

Open

$1.12

Previous Close

$0.90

Daily Range

$1.02 - $1.13

52-Week Range

$0.80 - $6.71

Estimated Earnings Date

Aug 19, 2026

RKDA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arcadia Biosciences

Industry

Food Products

Employees

8

CEO

Thomas J. Schaefer, CFA, MBA

Headquarters

Davis, CA 95618, US

RKDA Financials

Key Financial Metrics (TTM)

Gross Margin

34%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-158%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-6.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.86M

Shares Outstanding

2.06M

Volume

630.84K

Avg. Volume

1.02M

Financials (TTM)

Gross Profit

$1.76M

Operating Income

-$10.00M

EBITDA

-$9.96M

Operating Cash Flow

-$4.74M

Capital Expenditure

$0.00

Free Cash Flow

-$4.74M

Cash & ST Invst.

$4.56M

Total Debt

$0.00

Arcadia Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.10M

-8.3%

Gross Profit

$400.00K

-22.8%

Gross Margin

36.36%

N/A

Market Cap

$1.86M

N/A

Market Cap/Employee

$206.47K

N/A

Employees

9

N/A

Net Income

-$4.39M

-268.7%

EBITDA

-$771.00K

+36.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$3.72M

+17.8%

Total Debt

$0.00

-100.0%

Accounts Receivable

$425.00K

-88.1%

Inventory

$840.00K

-34.6%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.75%

N/A

Return on Invested Capital

-2.41%

N/A

Free Cash Flow

-$1.10M

+30.8%

Operating Cash Flow

-$1.10M

+30.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAPSCapstone Holding Corp.
$0.31+1.84%
CNEYCN Energy Group. Inc.
$0.81+1.25%
RETOReTo Eco-Solutions, Inc.
$2.76-6.76%
ENFYEnlightify Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.25+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.04-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$69.27-0.06%
LYGLloyds Banking Group Plc
$5.16-0.03%

Questions About RKDA

What is the current price of Arcadia Biosciences?

Arcadia Biosciences is trading at $1.05 per share.

What is the 52-week range for Arcadia Biosciences?

Over the past 52 weeks, Arcadia Biosciences has traded between $0.80 and $6.71.

How much debt does Arcadia Biosciences have?

As of the most recent reporting period, Arcadia Biosciences reported total debt of $0.00.

How much cash does Arcadia Biosciences have on hand?

Arcadia Biosciences reported $954.00K in cash and cash equivalents in its most recent financial results.

What is Arcadia Biosciences’s dividend yield?

Arcadia Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.